Wearable Bioimpedance Analyzer for Tracking Body Composition Changes
Key facts
- Who runs it
- University of Iowa
- Where
- Iowa City, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 60 people enrolled
- Started
- 14 Jul 2023
- Ended
- 8 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- InBody Band 2
- Record updated
- 30 June 2026
- Why it stopped
- Lack of feasibility due to study device issues.
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adults >/= 18 years
- BMI > 40kg/m2
- Presenting to bariatric arthroplasty clinic with desire for total joint arthroplasty procedure
- Owns a smartphone capable of handling iOS or Google Play apps
- Has a wrist circumference less than or equal to 7.7"
Who cannot take part
- Has a pacemaker or other electronic pacemaker placement
- Inability to complete study protocols
- Inability to stand unsupported for 60-90 seconds
- Does not own a smart phone capable of handling iOS or Google Play apps
- Has a wrist circumference greater than 7.7"
Where in United States
- University of Iowa Hospitals & ClinicsIowa City, United States
About the trial
What the trial wants to find out
Obesity, namely at body mass index (BMI) levels exceeding 40kg/m2 (class III obesity), is a risk factor for many diseases including osteoarthritis (OA). In arthroplasty, patients in this population frequently present for and are turned away from surgical intervention. Subsequently, efforts are made to decrease BMI through simple weight loss, yet these have been suggested as ineffective and counterproductive. Furthermore, simple weight loss may include muscle mass loss, which is an additional risk factor for surgery. At the University of Iowa Hospitals and Clinics Orthopedics Department, efforts have been made to encourage muscle mass gain and body fat loss over simple weight loss where progress has been tracked through stationary, multi-frequency bioimpedance analysis (BIA). BIA is a readily available technology offered to industry and consumers, and BIA has recently been incorporated into wearable devices. In the UIHC Orthopedics department, a novel clinic aimed at holistically serving the osteoarthritic-class III obese population for controlled and monitored weight loss through BIA.
Read full original descriptionShow less
This study, a randomized controlled trial, aims to recruit adult patients with class III obesity presenting to the arthroplasty-obesity clinic. While all patients will receive individual body composition coaching to increase muscle mass and decrease body fat mass, they will be randomized to one of two cohorts: the study group will receive a wearable BIA wristband (InBody BAND 2) and instruction on its use in addition to the standard coaching, and the control group will only receive the standard coaching.
This study aims to identify if the use of a wearable BIA wristband aids in the desired body composition changes. In addition, this study aims to quantify the body composition changes exhibited by each cohort. Finally, this study aims to track surgical outcomes for those patients that are indicated for total joint arthroplasty.
The 2 groups in the trial
- Wearable Device GroupTreatment being tested
Will be given InBody Band 2 to use while trying to achieve weight loss goal prior to total joint arthroplasty.
Treatment: InBody Band 2
- Control GroupNo study treatment, for comparison
Will not be given InBody Band 2 to use while trying to achieve weight loss goal prior to total joint arthroplasty.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 30 June 2026